Immunotherapy of multiple myeloma
- 31 July 2001
- journal article
- Published by Elsevier in Seminars in Hematology
- Vol. 38 (3) , 260-267
- https://doi.org/10.1016/s0037-1963(01)90018-6
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Innate ImmunityNew England Journal of Medicine, 2000
- Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myelomaBone Marrow Transplantation, 2000
- Chemokines — Chemotactic Cytokines That Mediate InflammationNew England Journal of Medicine, 1998
- Syndecan-1 Expression on Malignant Cells from the Blood and Marrow of Patients with Plasma Cell Proliferative Disorders and B-Cell Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1998
- Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytomaEuropean Journal of Immunology, 1996
- A plasmocyte selective monoclonal antibody (B‐B4) recognizes syndecan‐1British Journal of Haematology, 1996
- Circulating Clonotypic B Cells in the Biology of Multiple Myeloma: Speculations on the Origin of MyelomaLeukemia & Lymphoma, 1996
- Immunohistochemical localization of syndecan‐1 in normal and pathological human uterine cervixThe Journal of Pathology, 1994
- Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their TumorsNew England Journal of Medicine, 1992
- Idiotope‐specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II moleculesEuropean Journal of Immunology, 1986